Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07480109 · ClinicalTrials.gov registry record · NA
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
A NA study, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT07480109 is a NA study that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 75 participants.
The verdict
NCT07480109, a NA study, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Interventions
- BEHAVIORAL Protein Rich Foods
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07480109
The ClinicalTrials.gov registry entry for NCT07480109 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protein Rich Foods is the first listed.
NCT07480109 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07480109 about?
NCT07480109 is a clinical study titled "Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)". Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Bod...
What is the current status of trial NCT07480109?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-06-01. Estimated completion is 2027-09-30.
What interventions are being tested in trial NCT07480109?
The interventions under investigation include: Protein Rich Foods (BEHAVIORAL).
Who is sponsoring clinical trial NCT07480109?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.